Ucb SA
OTC:UCBJF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ucb SA
OTC:UCBJF
|
BE |
|
S
|
Sunsweet PCL
SET:SUN
|
TH |
|
N
|
Novo Nordisk A/S
XMUN:NOVA
|
DK |
|
Guerbet SA
PAR:GBT
|
FR |
|
S
|
Suncor Energy Inc (Canada)
XMUN:SM3
|
CA |
|
H
|
Healius Ltd
OTC:PHCRF
|
AU |
Intrinsic Value
Is UCBJF undervalued or overvalued?
See the intrinsic value estimate for 
Ucb SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
UCBJF looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with UCBJF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Ucb Does
UCB SA is a Belgian biopharmaceutical company that develops and sells prescription medicines for people with serious immune and nervous system diseases. Its main products are treatments for conditions such as epilepsy, Parkinson’s-related movement problems, and immune-mediated disorders like psoriasis, arthritis, and other autoimmune diseases. The company spends heavily on research and clinical testing because its business depends on discovering, proving, and getting approval for new medicines.
- Headquarters
- Belgium BE
- Employees
- 9 765
- IPO date
- Jan 2, 1987
Earnings Waterfall
Ucb SA
The intrinsic value for Ucb SA (UCBJF) under the Base Case is hidden USD.
Compared with the current market price of 293.39 USD, the stock appears hidden.